HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xia, J. Articles by Koschinsky, M. L. Search for Related Content PubMed PubMed Citation Articles by Xia, J. Articles by Koschinsky, M. L. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 1578-1584, October 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity

Correspondence to: Marlys L. Koschinsky

Although elevated plasma concentrations of lipoprotein [a] (Lp[a]) are considered to be a risk factor for atherosclerosis, the mechanisms by which Lp[a] mediates its pathogenic effects have not been conclusively determined. The apolipoprotein [a] (apo[a]) component of Lp[a] confers unique structural properties to this lipoprotein, including the ability to bind to lysine residues in biological substrates. It has been shown, however, that only a fraction of plasma Lp[a] (Lp[a]-Lys⁺) binds to lysine-Sepharose in vitro. The nature of the non-lysine-binding Lp[a] fraction in plasma (Lp[a]-Lys^-) is currently unknown. In the present study, the Lp[a]-Lys⁺ fraction was determined in the plasma of six unrelated individuals; the Lp[a]-Lys⁺ fraction in these plasma samples ranged from 37 to 48%. Interestingly, purification of the Lp[a] by density gradient ultracentrifugation followed by gel filtration and ion-exchange chromatography resulted in progressive increases in the Lp[a]-Lys⁺ fraction. Addition of either purified low density lipoprotein (LDL) or fibronectin to the purified Lp[a] at a 1:1 molar ratio reduced the Lp[a]-Lys⁺ fraction (maximal decrease of 34 and 20%, respectively) whereas addition of both fibronectin and LDL to the purified Lp[a] resulted in a further decrease (45% maximally) in this fraction. Similar results were obtained by using a recombinant expression system for apo[a]: addition of a 4-fold molar excess of either LDL or fibronectin to conditioned medium containing metabolically labeled recombinant apo[a] reduced the Lys⁺ fraction by 49 and 23%, respectively.

Taken together, our data suggest that the lysine-binding heterogeneity of plasma Lp[a] is not primarily an intrinsic property of the lipoprotein, but rather results in large part from its ability to noncovalently associate with abundant plasma components such as LDL and fibronectin. These interactions appear to mask the lysine-binding site in apo[a] kringle IV type 10, which mediates the interaction of Lp[a] with lysine-Sepharose. The contribution of these interactions to the function of Lp[a] in vivo remains to be investigated.—Xia, J., L. F. May, and M. L. Koschinsky. Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity. J. Lipid Res. 2000. 41: 1578;–1584.

Supplementary key words: apolipoprotein [a], low density lipoprotein, kringles, fibronectin, -aminocaproic acid, atherosclerosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Tsimikas, L. D. Tsironis, and A. D. Tselepis New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A2 in Atherosclerosis and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2094 - 2099. [Abstract] [Full Text] [PDF]